Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences

      Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences

      Medical Dialogues Bureau8 May 2019 9:15 AM IST
      Yasir Rawjee joins Glenmark Life Sciences from Mylan, where most recently he was the Head of Global API Operations, Glenmark Pharmaceuticals said in a...
      Pfizer gets USFDA nod for potential blockbuster heart drug Tafamidis

      Pfizer gets USFDA nod for potential blockbuster heart drug Tafamidis

      Medical Dialogues Bureau7 May 2019 9:45 AM IST
      Pfizer, which has touted tafamidis as a potential blockbuster product, set a list price of $225,000 a year for the medicine, which would be sold under...
      Jacobus Pharma wins USFDA approval for Ruzurgi to treat rare autoimmune disorder

      Jacobus Pharma wins USFDA approval for Ruzurgi to treat rare autoimmune disorder

      Medical Dialogues Bureau7 May 2019 9:25 AM IST
      The drug, Ruzurgi, was approved for use in patients aged between 6 and 17, the FDA said Lambert-Eaton myasthenic syndrome, which affects about three...
      China war on healthcare costs lure Indian drugmaker Sun Pharma: Report

      China war on healthcare costs lure Indian drugmaker Sun Pharma: Report

      Medical Dialogues Bureau6 May 2019 9:15 AM IST
      China has rolled out an ambitious multi-city bulk procurement program that's driving down prices and providing an opening for Indian manufacturers...
      Novo Nordisk Q1 profit tops forecast as new diabetes drug Ozempic shines

      Novo Nordisk Q1 profit tops forecast as new diabetes drug Ozempic shines

      Medical Dialogues Bureau5 May 2019 9:15 AM IST
      Sales of the treatment, branded Ozempic, rose to 1.4 billion Danish crowns ($209 million) in the quarter, trumping analyst forecasts for 1.3 billion...
      McKesson to pay $37 million to settle West Virginia opioid lawsuit

      McKesson to pay $37 million to settle West Virginia opioid lawsuit

      Medical Dialogues Bureau5 May 2019 9:00 AM IST
      Under the agreement, McKesson will pay $14.5 million this year and another $4.5 million annually for the next five years. It said the money will go...
      Narcotics Control Bureau seals illegal Ketamine factory in Hyderabad

      Narcotics Control Bureau seals illegal Ketamine factory in Hyderabad

      Medical Dialogues Bureau4 May 2019 9:30 AM IST
      This came a day after the NCB arrested a Bengaluru native for producing Ketamine, a medication mainly used for starting and maintaining...
      USFDA allows sale of breast implants tied to rare cancer

      USFDA allows sale of breast implants tied to rare cancer

      Medical Dialogues Bureau4 May 2019 9:15 AM IST
      Ahead of a March meeting, the FDA revealed for the first time that it had received more than 350,000 reports related to breast implants over the last...
      Pharma Ex Chairman held guilty of bribing doctors in millions to push opioid

      Pharma Ex Chairman held guilty of bribing doctors in millions to push opioid

      Medical Dialogues Bureau3 May 2019 10:05 AM IST
      The 76-year-old former chairman of Insys Therapeutics was found guilty of racketeering conspiracy after 15 days of jury deliberations.BOSTON: A...
      Union Health Minister asked not to receive donations from JnJ for TB Control Program

      Union Health Minister asked not to receive donations from JnJ for TB Control Program

      Medical Dialogues Bureau3 May 2019 9:15 AM IST
      Recently, Johnson & Johnson (JnJ) had announced to provide an additional 10,000 courses of tuberculosis drug bedaquiline (BDQ) to the Indian...
      Novartis division strikes deal with Eir Genix to market biosimilar of Herceptin

      Novartis division strikes deal with Eir Genix to market biosimilar of Herceptin

      Medical Dialogues Bureau2 May 2019 9:15 AM IST
      EirGenix will be responsible for development and manufacturing, while Sandoz has the right to commercialize in all markets except China and Taiwan....
      Pfizer Q1 profit up 9 percent on higher drug sales, lower costs

      Pfizer Q1 profit up 9 percent on higher drug sales, lower costs

      Medical Dialogues Bureau2 May 2019 9:07 AM IST
      Pfizer modestly lifted its full-year profit forecast. The company also bought back $8.9 billion worth of shares in the first quarter, a jump from the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok